Celcuity
Develops and prepares to commercialize gedatolisib therapies for advanced breast and prostate cancers.
$90.10
After-hours close+1.60 (+1.81%)
At close$88.50(−5.08%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.50 | — | — |
| Aug 2026 | −$1.16 | −$1.44 | −24.1% |
| May 2026 | −$1.07 | −$0.97 | +9.3% |
| Mar 2026 | −$1.06 | −$0.97 | +8.5% |
| Nov 2025 | −$1.02 | −$0.92 | +9.8% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$1.50 | — | — | $4.3M | — | — |
| Aug 13, 2026 | −$1.16 | −$1.44 | −24.1% | $4.4M | $94.0K | −97.9% |
| May 14, 2026 | −$1.07 | −$0.97 | +9.3% | $2.9M | — | — |
| Mar 25, 2026 | −$1.06 | −$0.97 | +8.5% | $1.3M | — | — |
| Nov 12, 2025 | −$1.02 | −$0.92 | +9.8% | — | — | — |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 15, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 23, 2022 | ||||||
| Nov 8, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 10, 2021 | ||||||
| Feb 16, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 26, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 14, 2018 | ||||||
| Mar 15, 2018 | ||||||
| Nov 13, 2017 | ||||||
| Sep 20, 2017 | ||||||
| Mar 31, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||